We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
e11541 Background: Triple-negative breast cancer certainly becomes the interested subgroup of breast cancer because of poorer outcomes. In term of clinicopathologic features, response rate in chemotherapeutic agents and survival outcomes relatively differ from hormone positive and HER-2 positive groups. So we would like to identify the prevalence and(More)
  • 1